169 related articles for article (PubMed ID: 22215955)
1. Polymorphisms associated with the risk of lung cancer in a healthy Mexican Mestizo population: Application of the additive model for cancer.
Pérez-Morales R; Méndez-Ramírez I; Castro-Hernández C; Martínez-Ramírez OC; Gonsebatt ME; Rubio J
Genet Mol Biol; 2011 Oct; 34(4):546-52. PubMed ID: 22215955
[TBL] [Abstract][Full Text] [Related]
2. Genetic susceptibility to lung cancer based on candidate genes in a sample from the Mexican Mestizo population: a case-control study.
Pérez-Morales R; Méndez-Ramírez I; Moreno-Macias H; Mendoza-Posadas AD; Martínez-Ramírez OC; Castro-Hernández C; Gonsebatt ME; Rubio J
Lung; 2014 Feb; 192(1):167-73. PubMed ID: 24357096
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of CYP1A1*2C, GSTM1*0, and GSTT1*0 in a Mexican Mestizo population: a similitude analysis.
Pérez-Morales R; Castro-Hernández C; Gonsebatt ME; Rubio J
Hum Biol; 2008 Aug; 80(4):457-65. PubMed ID: 19317600
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north indian population.
Sobti RC; Sharma S; Joshi A; Jindal SK; Janmeja A
Mol Cell Biochem; 2004 Nov; 266(1-2):1-9. PubMed ID: 15646021
[TBL] [Abstract][Full Text] [Related]
5. Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population.
Sreeja L; Syamala V; Hariharan S; Madhavan J; Devan SC; Ankathil R
J Hum Genet; 2005; 50(12):618-27. PubMed ID: 16228113
[TBL] [Abstract][Full Text] [Related]
6. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people.
Quiñones L; Lucas D; Godoy J; Cáceres D; Berthou F; Varela N; Lee K; Acevedo C; Martínez L; Aguilera AM; Gil L
Cancer Lett; 2001 Dec; 174(1):35-44. PubMed ID: 11675150
[TBL] [Abstract][Full Text] [Related]
7. Association of xenobiotic-metabolizing genes polymorphisms with cervical cancer risk in the Tunisian population.
Helaoui A; Sfar S; Boudhiba N; Dehghanian F; Dehbashi M; Bouchahda H; Hojati Z; Kenani A
Mol Biol Rep; 2023 Feb; 50(2):949-959. PubMed ID: 36376536
[TBL] [Abstract][Full Text] [Related]
8. [Association between genetic polymorphism of metabolizing enzymes and DNA repairing enzymes and the susceptibility of lung cancer in Henan population].
Wang N; Wu Y; Zhou X; Wu Y
Wei Sheng Yan Jiu; 2012 Mar; 41(2):251-6. PubMed ID: 22611936
[TBL] [Abstract][Full Text] [Related]
9. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
[TBL] [Abstract][Full Text] [Related]
10. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.
Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF
Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991
[TBL] [Abstract][Full Text] [Related]
11. Genotype frequencies of polymorphic GSTM1, GSTT1, and cytochrome P450 CYP1A1 in Mexicans.
Montero R; Araujo A; Carranza P; Mejía-Loza V; Serrano L; Albores A; Salinas JE; Camacho-Carranza R
Hum Biol; 2007 Jun; 79(3):299-312. PubMed ID: 18078203
[TBL] [Abstract][Full Text] [Related]
12. Combined analysis of EPHX1, GSTP1, GSTM1 and GSTT1 gene polymorphisms in relation to chronic obstructive pulmonary disease risk and lung function impairment.
Lakhdar R; Denden S; Knani J; Leban N; Daimi H; Hassine M; Lefranc G; Chibani JB; Khelil AH
Dis Markers; 2011; 30(5):253-63. PubMed ID: 21734345
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of lung cancer with polymorphisms of CYP1A1, GSTM1, GSTM3, GSTT1 and GSTP1 genotypes in the population of Inner Mongolia region.
Jiang XY; Chang FH; Bai TY; Lv XL; Wang MJ
Asian Pac J Cancer Prev; 2014; 15(13):5207-14. PubMed ID: 25040976
[TBL] [Abstract][Full Text] [Related]
14. Genetic variability among Mexican Mestizo and Amerindian populations based on three ABCB1 polymorphisms.
Favela-Mendoza AF; Rangel-Villalobos H; Fricke-Galindo I; Ortega-Vázquez A; Martínez-Cortés G; López-López M
Mol Biol Rep; 2018 Dec; 45(6):2525-2533. PubMed ID: 30317428
[TBL] [Abstract][Full Text] [Related]
15. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of CYP1a1, CYP2e1, GSTM1, GSTT1, and TP53 genes in Amerindians.
Gaspar PA; Hutz MH; Salzano FM; Hill K; Hurtado AM; Petzl-Erler ML; Tsuneto LT; Weimer TA
Am J Phys Anthropol; 2002 Nov; 119(3):249-56. PubMed ID: 12365037
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
[TBL] [Abstract][Full Text] [Related]
18. The GSTM1null (deletion) and MGMT84 rs12917 (Phe/Phe) haplotype are associated with bulky DNA adduct levels in human leukocytes.
Molina E; Pérez-Morales R; Rubio J; Petrosyan P; Cadena LH; Arlt VM; Phillips DH; Gonsebatt ME
Mutat Res Genet Toxicol Environ Mutagen; 2013 Dec; 758(1-2):62-8. PubMed ID: 24084248
[TBL] [Abstract][Full Text] [Related]
19.
Fernandes GM; Russo A; Proença MA; Gazola NF; Rodrigues GH; Biselli-Chicote PM; Silva AE; Netinho JG; Pavarino ÉC; Goloni-Bertollo EM
World J Gastroenterol; 2016 Dec; 22(45):9974-9983. PubMed ID: 28018104
[TBL] [Abstract][Full Text] [Related]
20. Combined effect of GSTM1, GSTT1 and GSTP1 polymorphisms on histological subtypes of lung cancer.
Sobti RC; Kaur P; Kaur S; Janmeja AK; Jindal SK; Kishan J; Raimondi S
Biomarkers; 2008 May; 13(3):282-95. PubMed ID: 18415801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
